GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » Debt-to-Revenue

Greenfern Industries (NZSE:GFI) Debt-to-Revenue : 1.18 (As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Greenfern Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was NZ$0.65 Mil. Greenfern Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was NZ$0.00 Mil. Greenfern Industries's annualized Revenue for the quarter that ended in Mar. 2023 was NZ$0.55 Mil. Greenfern Industries's annualized Debt-to-Revenue for the quarter that ended in Mar. 2023 was 1.18.


Greenfern Industries Debt-to-Revenue Historical Data

The historical data trend for Greenfern Industries's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenfern Industries Debt-to-Revenue Chart

Greenfern Industries Annual Data
Trend Mar22 Mar23
Debt-to-Revenue
- 1.18

Greenfern Industries Semi-Annual Data
Mar22 Mar23
Debt-to-Revenue - 1.18

Competitive Comparison of Greenfern Industries's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Greenfern Industries's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenfern Industries's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenfern Industries's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Greenfern Industries's Debt-to-Revenue falls into.



Greenfern Industries Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Greenfern Industries's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.652 + 0) / 0.551
=1.18

Greenfern Industries's annualized Debt-to-Revenue for the quarter that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.652 + 0) / 0.551
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Mar. 2023) Revenue data.


Greenfern Industries Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenfern Industries (NZSE:GFI) Business Description

Traded in Other Exchanges
N/A
Address
115 Queen Street, Level 8, General Capital House, Auckland, NTL, NZL, 1040
Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.